Determination of GNF6702 permeability in Caco-2 assay

SK Shilpi Khare
AN Advait S. Nagle
AB Agnes Biggart
YL Yin H. Lai
FL Fang Liang
LD Lauren C. Davis
SB S. Whitney Barnes
CM Casey J. N. Mathison
EM Elmarie Myburgh
MG Mu-Yun Gao
JG J. Robert Gillespie
XL Xianzhong Liu
JT Jocelyn L. Tan
MS Monique Stinson
IR Ianne C. Rivera
JB Jaime Ballard
VY Vince Yeh
TG Todd Groessl
GF Glenn Federe
HK Hazel X. Y. Koh
JV John D. Venable
BB Badry Bursulaya
MS Michael Shapiro
PM Pranab K. Mishra
GS Glen Spraggon
AB Ansgar Brock
JM Jeremy C. Mottram
FB Frederick S. Buckner
SR Srinivasa P. S. Rao
BW Ben G. Wen
JW John R. Walker
TT Tove Tuntland
VM Valentina Molteni
RG Richard J. Glynne
FS Frantisek Supek
request Request a Protocol
ask Ask a question
Favorite

A 96-Multiwell Insert System (BD Biosciences) was used for the Caco-2 cell culture and permeability assay as described previously42. Caco-2 cells were seeded onto insert wells at a density of 1.48 × 105 cells per ml and allowed to grow for 19–23 days before assays. To measure both absorptive (apical to basolateral [A-B]) and secretory (basolateral to apical [B-A]) compound transport, a solution of GNF6702 at 10 μM concentration in 0.5% DMSO were added to donor wells. The plate was incubated at 37°C for 2 hours, with samples taken at the beginning and end of the incubation from both donor and acceptor wells. The concentration of GNF6702 was determined by LC-MS/MS.

Apparent drug permeability (Papp) was calculated using the following equation:

where dQ/dt is the total amount of a test compound transported to the acceptor chamber per unit of time (nmol/s), A is the surface area of the transport membrane (0.0804 cm2), Cin is the initial compound concentration in the donor chamber (10 μM), and Papp is expressed as cm/s).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A